SEC Filing Summary: Intrexon Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Intrexon Corporation on January 13, 2016. The filing serves as a Regulation FD disclosure regarding a presentation scheduled for the 2016 J.P. Morgan Healthcare Conference. The registrant is incorporated in Virginia with principal executive offices in Germantown, Maryland.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural disclosure of an upcoming investor presentation rather than a financial results report.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing solely announces the delivery of an investor presentation and incorporates the presentation slides as Exhibit 99.1.
Guidance, Outlook, and Risks
Management commentary, guidance, and risk factors are contained within the attached investor presentation (Exhibit 99.1), which is incorporated by reference. The filing explicitly states that the information in Item 7.01 and the exhibit will not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the content of the investor presentation slides (Exhibit 99.1) for specific financial guidance and strategic outlook.
- Note that the presentation materials are furnished but not "filed" under Section 18 liability standards.
- Confirm the company's current name is Intrexon Corporation; the request metadata mentions "PRECIGEN, INC." which is not referenced in this filing text.
- Review the presentation for any new risks or contingencies discussed at the J.P. Morgan Healthcare Conference.